 Home > Medical News > Medicines Company News > The world's first nasopharyngeal cancer immunotherapy drug-Tuoyi New Indications National Launch Conference held

The world's first nasopharyngeal cancer immunotherapy drug-Tuoyi New Indications National Launch Conference held

 Last Update: 2021-07-15
 Source: Internet
 Author: User

Tags

oil based lubricants

harvard drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Professor Xu Ruihua,

Among 92 patients with relapsed/metastatic nasopharyngeal carcinoma who had failed at least second-line chemotherapy in the POLARIS-02 study, the objective response rate (ORR) of teriprizumab monotherapy was 23.

In addition, in the field of first-line treatment, the JUPITER-02 study, which also has Professor Ruihua Xu as the main investigator, has also reached the main research endpoint

Professor Mai Haiqiang said, “Treplimumab, as a drug produced by an innovative Chinese pharmaceutical company, leads the international treatment plan and defines a new treatment method for nasopharyngeal cancer through global multi-center clinical research, which is the first-line immunotherapy for nasopharyngeal cancer.

Dr.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.